Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice - Biologie-Santé Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) Endocrine reviews Année : 2023

Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice

Moshe Phillip
Revital Nimri
Richard Bergenstal
Katharine Barnard-Kelly
Thomas Danne
Roman Hovorka
Boris Kovatchev
Christopher Parkin
Stephanie Amiel
Lia Bally
Roy Beck
Sarah Biester
  • Fonction : Auteur
Torben Biester
Julia Blanchette
Charlotte Boughton
Marc Breton
Sue Brown
Bruce Buckingham
Albert Cai
  • Fonction : Auteur
Anders Carlson
Jessica Castle
Pratik Choudhary
Kelly Close
  • Fonction : Auteur
Claudio Cobelli
Amy Criego
  • Fonction : Auteur
Elizabeth Davis
Carine de Beaufort
Martin de Bock
Daniel Desalvo
J Hans Devries
Klemen Dovc
Francis Doyle
  • Fonction : Auteur
Laya Ekhlaspour
Naama Fisch Shvalb
Gregory Forlenza
  • Fonction : Auteur
Geraldine Gallen
  • Fonction : Auteur
Satish Garg
  • Fonction : Auteur
Dana Gershenoff
  • Fonction : Auteur
Linda Gonder-Frederick
Ahmad Haidar
  • Fonction : Auteur
Sara Hartnell
  • Fonction : Auteur
Lutz Heinemann
Simon Heller
  • Fonction : Auteur
Irl Hirsch
Korey Hood
Diana Isaacs
David Klonoff
  • Fonction : Auteur
Olga Kordonouri
  • Fonction : Auteur
Aaron Kowalski
  • Fonction : Auteur
Lori Laffel
Julia Lawton
  • Fonction : Auteur
Rayhan Lal
Lalantha Leelarathna
David Maahs
Helen Murphy
  • Fonction : Auteur
Kirsten Nørgaard
  • Fonction : Auteur
David O'Neal
  • Fonction : Auteur
Sean Oser
Tamara Oser
Michael Riddell
David Rodbard
Steven Russell
  • Fonction : Auteur
Desmond Schatz
Viral Shah
Jennifer Sherr
Gregg Simonson
R Paul Wadwa
Candice Ward
  • Fonction : Auteur
Stuart Weinzimer
Emma Wilmot
Tadej Battelino

Résumé

The significant and growing global prevalence of diabetes continues to challenge people with diabetes (PwD), healthcare providers and payers. While maintaining near-normal glucose levels has been shown to prevent or delay the progression of the long-term complications of diabetes, a significant proportion of PwD are not attaining their glycemic goals. During the past six years, we have seen tremendous advances in automated insulin delivery (AID) technologies. Numerous randomized controlled trials and real-world studies have shown that the use of AID systems is safe and effective in helping PwD achieve their long-term glycemic goals while reducing hypoglycemia risk. Thus, AID systems have recently become an integral part of diabetes management. However, recommendations for using AID systems in clinical settings have been lacking. Such guided recommendations are critical for AID success and acceptance. All clinicians working with PwD need to become familiar with the available systems in order to eliminate disparities in diabetes quality of care. This report provides much-needed guidance for clinicians who are interested in utilizing AIDs and presents a comprehensive listing of the evidence payers should consider when determining eligibility criteria for AID insurance coverage.

Dates et versions

hal-03771661 , version 1 (07-09-2022)

Identifiants

Citer

Moshe Phillip, Revital Nimri, Richard Bergenstal, Katharine Barnard-Kelly, Thomas Danne, et al.. Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice. Endocrine reviews, 2023, 44 (2), pp.254-280. ⟨10.1210/endrev/bnac022⟩. ⟨hal-03771661⟩
67 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More